Home Situations IONS — Profile and price weak
Situation · 2026-07-24

IONS — Profile and price weak

Discounted for Persistent Inefficiency

Updated 2026-07-21 · Ref: Biotechnology
Key metrics — 2026-07-21
Peer score
39
Quality pct
21
Valuation pct
30
52w drawdown
-38.3%
21d vs sector
-38.5%
Peer group
Biotechnology
Situation summary

Ionis trades at a discount because margin weakness and capital inefficiency persist. The market sees growth, not profitability. -33.4% operating margin is a red flag. Only sustained positive returns would change the story.

Published by AssetNext · 2026-07-10

All companies with this signal today

View full list: Profile and price weak →

Related pages for IONS
Full peer analysis for Ionis Pharmaceuticals, Inc. →Similar companies to IONSIONS peersAll IONS comparisonsRussell 1000 context
Signal history — last 30 days
Date Signal Peer score Drawdown 21d vs sector
2026-07-21 Profile and price weak 39 -38.3% -38.5%
2026-07-15 Profile and price weak 39 -36.7% -40.8%
2026-07-09 Profile and price weak 39 -25.7% -29.0%

See IONS's full peer analysis

Break down IONS's structural position across all peer dimensions with the interactive app.

Open IONS in AssetNext →